跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MAO-1
首页
药物
MAO-1
MAO-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
MAO-B inhibitor DRG-MAOB-1 for use in treatment of neurodegenerative diseases
申请人: BAHCESEHIR UNIV
优先权: 2020
US
PREPARATION AND USE OF NOVEL MAO-B INHIBITOR CONTAINING TETRALIN-1-AMINE STRUCTURE
申请人: UNIV CHONGQING MEDICAL
优先权: 2024
CN
WO
2 件公开
3- (4- (2-dihydroisoxazol-3-ylpyridin-5-yl) phenyl) -5-triazol-1-ylmethyloxazolidin-2-one derivaives as mao inhibitors for the treatment of bacterial infections
申请人: ASTRAZENECA AB
优先权: 2004
CN
3-(4-(2-DIHYDROISOXAZOL-3-YLPYRIDIN-5-YL)PHENYL)-5-TRIAZOL-1-YLMETHYLOXAZOLIDIN-2-ONE DERIVATIVES AS MAO INHIBITORS FOR THE TREATMENT OF BACTERIAL INFECTIONS
申请人: ASTRAZENECA AB
优先权: 2004
US
Isobenzofuran-1 (3H)-ketone compound as well as preparation method, pharmaceutical composition and application thereof
申请人: INST MATERIA MEDICA CAMS
优先权: 2023
CN
Use of monoamine oxidase inhibitors for manufacture of drugs intended for treatment of obesity
申请人: SANOFI SYNTHELABO
优先权: 1999
CN
Chlamydomonas reinhardtii protein extraction and MAO-A inhibitory peptide preparation method and application
申请人: UNIV SOUTH CHINA TECH
优先权: 2024
CN
Compositions and methods to prevent toxicity of antiinflammatory agents and enhance their efficacy
申请人: THOMAS THOMAS N
优先权: 2004
US
2 件公开
药物
反馈